Salvina Therapeutics

About:

Salvina Therapeutics is developing novel antibodies targeting TNF to overcome efficacy barriers in inflammatory and autoimmune diseases.

Top Investors: BaseLaunch

Description:

Salvina Therapeutics is working to break through efficacy barriers in inflammatory and autoimmune illnesses. The business discovered a novel epitope for specifically targeting TNF, culminating in the development of antibodies with a novel mode of action.